Announcements Trials
Browse Landscape

Phase

Phase 2 105Phase 1 23Phase 1/2 20Phase 3 9Phase NA 4Phase 2/3 2Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Lymphoma, Follicular 1Dermatitis, Atopic 1

Interventions

Cyclophosphamide 27Vincristine 24Dexamethasone 22Rituximab 21Methotrexate 21Cytarabine 21Mercaptopurine 16Doxorubicin 15Etoposide 13Asparaginase 13Daunorubicin 12Prednisone 10Prednisolone 10Granulocyte Colony-Stimulating Factor 10Ifosfamide 8Idarubicin 8fludarabine 7pegylated granulocyte colony-stimulating factor 6Thioguanine 6Teniposide 6Vindesine 5Brentuximab Vedotin 5ibrutinib 4fludarabine phosphate 4Stem Cell Transplantation 4Gemcitabine 4Cisplatin 4Aprepitant 4zanubrutinib 3prednylidene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Tacrolimus × Lymphoid × Clear all
NCT01745159 2014-08-05

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Astellas Pharma Inc

Phase 4 Completed
125 enrolled
Lymphoid

Dermatitis, Atopic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡